Skip to main content
  • Retraction Note
  • Open access
  • Published:

Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT

The Original Article was published on 08 November 2019

Retraction Note: Cancer Cell Int (2019) 19:284

The Editors-in-Chief have retracted this article. Concerns were raised regarding a number of figures, specifically:

  • Figure 2f appears to overlap with Figure 8B and 8D from [1].

  • Figure 6d appears to overlap with Figure 6F from [2].

  • Figure 4c appears to overlap with Figure 3C from [3].

  • Figure 2D appears overlap with Figure 1F from [4].

The Editors-in-Chief therefore no longer have confidence in the results and conclusions this article.

The authors agree with this retraction.


  1. Miao Y, Lu M, Yan Q, Li S, Feng Y. Inhibition of proliferation, migration, and invasion by knockdown of pyruvate kinase-M2 (PKM2) in ovarian cancer SKOV3 and OVCAR3 cells. Oncol Res. 2016;24(6):463–75.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Liang T, Ye X, Liu Y, Qiu X, Li Z, Tian B, Yan D. FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin. Exp Mol Med. 2018;50(12):1–12.

    Article  CAS  PubMed  Google Scholar 

  3. Zhang S, Wang Y, Chen S, Li J. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells. Biomed Pharmacother. 2018;106:1396–403.

    Article  CAS  PubMed  Google Scholar 

  4. Shi J, Wang Q, Li H, Huang Q. Silencing of USP22 suppresses high glucose-induced apoptosis, ROS production and inflammation in podocytes Mol. BioSyst. 2016;12:1445–56.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Kangwu Chen or Huilin Yang.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, B., Wang, G., Wang, Q. et al. Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT. Cancer Cell Int 23, 216 (2023).

Download citation

  • Accepted:

  • Published:

  • DOI: